🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Filipa Lynce

Harvard University

ORCID: 0000-0001-6615-7076

Also affiliated with Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

Biochemistry, Genetics and Molecular BiologyEngineeringImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.329Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf088

Top 52%

0.329DataRank

Top 52%7 citations

Samuel M. Niman, Megumi Kai, Sean G. Ryan, Elizabeth Troll, Li Li +16 more

Papers

Driven by 14 papers — median percentile 48. Top paper: “Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer”.

Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer

Therapeutic Advances in Medical Oncology(2022)10.1177/17588359221113269

N/A

0.672DataRank · unranked

15 citations

Jennifer L. Guerriero, Sergey Naumenko, Shom Goel, Meredith M. Regan, Jiani Hu +10 more

Implantation of engineered adipocytes suppresses tumor progression in cancer models

Nature Biotechnology(2025)10.1038/s41587-024-02551-2

N/A

0.550DataRank · unranked

38 citations

Kelly An, Yusuke Ito, Bhushan N. Kharbikar, Rory R Sheng, Beatriz Paredes +23 more

Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer

Translational Behavioral Medicine(2023)10.1093/tbm/ibac106

N/A

0.357DataRank · unranked

5 citations

Kristi D. Graves, Katie Fiallos, Marc D. Schwartz, Beth N. Peshkin, Heidi E. Hamilton +8 more

Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf088

Top 52%

0.329DataRank

Top 52%7 citations

Samuel M. Niman, Megumi Kai, Sean G. Ryan, Elizabeth Troll, Li Li +16 more

Copy Number Variation in Inflammatory Breast Cancer

Cells(2023)10.3390/cells12071086

N/A

0.269DataRank · unranked

5 citations

Andrea O’Hara, Kornelia Polyak, Faina Nakhlis, Beth T. Harrison, Antonio Giordano +3 more

885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0885

N/A

0.104DataRank · unranked

1 citations

Filipa Lynce, Xue Geng, Edward T. Richardson, Candace Mainor, Mei Wei +14 more

AXALAP: Phase Ib study of axatilimab in combination with olaparib in BRCA1/2 and PALB2 -associated metastatic HER2-negative breast cancer (BC).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps1143

N/A

0DataRank · unranked

0 citations

Adela Rodríguez Hernandez, Siddhartha Yadav, Ryan Buehler, Grace Augdahl, Tasnim Rahman +9 more

Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07795-3

N/A

0DataRank · unranked

0 citations

N Sridhar, Megumi Kai, Wenli Dong, Shen Yu, Savitri Krishnamurthy +14 more

982 Immune mediated mechanisms of PARPi resistance in BRCA1-associated triple negative breast cancer (TNBC)

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0982

N/A

0DataRank · unranked

0 citations

Anita K. Mehta, Madeline G Townsend, Madisson Oliwa, Kelly F Zheng, Patrice A. Lee +6 more

Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12069

N/A

0DataRank · unranked

0 citations

Ana Barac, Filipa Lynce, Xue Geng, Chau T. Dang, Anthony F. Yu +13 more

T cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL-1 and TNFα Inflammation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.20.508732

N/A

0DataRank · unranked

2 citations

Sophia M. Guldberg, Barzin Y. Nabet, Jie Zeng Yu, Eun Ji Kim, Kamir J. Hiam-Galvez +9 more

Implantation of engineered adipocytes that outcompete tumors for resources suppresses cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.28.534564

N/A

0DataRank · unranked

3 citations

Rory Sheng, Elizabeth Murray, Yusuke Ito, Michael Brück, Cassidy Biellak +10 more

Trends in the Use of Cardiac Imaging for Women with Newly Diagnosed Breast Cancer

Journal of Cardiovascular Translational Research(2020)10.1007/s12265-020-10023-6

N/A

0DataRank · unranked

11 citations

Claudine Isaacs, Nawar Shara, Filipa Lynce, Sameer Desale, Kevin Haynes +2 more

T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0416

N/A

0DataRank · unranked

13 citations

Sophia M. Guldberg, Barzin Y. Nabet, Jie Zeng, Eun Ji Kim, Kamir J. Hiam-Galvez +9 more